Basic information
- Name:
Pregna-1,4-diene-3,20-dione,11,17,21-trihydroxy-6-methyl-, (6a,11b)-
- Superlist Name:
- Methylprednisolone
- CAS No.:
83-43-2
- Molecular Structure:

- Formula:
- C22H30O5
- Molecular Weight:
- 374.52
- Deleted CAS:
- 570-35-4|121673-01-6
- Synonyms:
- Pregna-1,4-diene-3,20-dione,11b,17,21-trihydroxy-6a-methyl- (7CI,8CI);11b,17,21-Trihydroxy-6a-methylpregna-1,4-diene-3,20-dione;6a-Methyl-11b,17a,21b-trihydroxy-1,4-pregnadiene-3,20-dione;6a-Methylprednisolone;Besonia;Duralone;M-Prednisol;Medorol;Medralone;Medrol;Metastab;Methylprednisolone;Metilbetasone;Metrisone;NSC 19987;Prednol;Promacortine;Suprametil;Urbason;Urbasone;Wyacort;Methylphenisolone;
- EINECS:
- 201-476-4
- Density:
- 1.28 g/cm3
- Melting Point:
- 228-237 °C (dec.)
- Boiling Point:
- 571.8 °C at 760 mmHg
- Flash Point:
- 313.7 °C
- Appearance:
- White to off-white crystalline powder
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety Description:
- 22-36-26 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Consensus Reports
Reported in EPA TSCA Inventory.
Specification
The Methylprednisolone with cas registry number of 83-43-2 has other registry numbers which are 121673-01-6 and 570-35-4. Its EINECS registry number is 201-476-4. It belongs to the classes of Miscellaneous Biochemicals; Biochemistry; Hydroxyketosteroids; Steroids; Intermediates & Fine Chemicals; Pharmaceuticals. This chemical is also known as Promacortine, Reactenol, Sieropresol, Solomet, Solu-medrol, Summicort; Suprametil.Its systematic name is called (6alpha,11beta)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione. And its IUPAC name is also called(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one. It is white to off-white crystalline powder.
Physical properties about this chemical are: (1)ACD/LogP: 1.99; (2) # of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 1.99; (4)ACD/LogD (pH 7.4): 1.99; (5)ACD/BCF (pH 5.5): 19.06; (6)ACD/BCF (pH 7.4): 19.06; (7)ACD/KOC (pH 5.5): 287.01; (8)ACD/KOC (pH 7.4): 287.01; (9)#H bond acceptors: 5; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 61.83 Å2; (13)Index of Refraction: 1.602; (14)Molar Refractivity: 100.08 cm3; (15)Molar Volume: 291.4 cm3; (16)Surface Tension: 58.1 dyne/cm; (17)Density: 1.28 g/cm3; (18)Flash Point: 313.7 °C; (19)Enthalpy of Vaporization: 98.47 kJ/mol; (20)Boiling Point: 571.8 °C at 760 mmHg; (21)Vapour Pressure: 1.86E-15 mmHg at 25°C; (22)Refractive index: 82 ° (C=1, Dioxane); (23)Melting Point: 228-237°C.
Uses of Methylprednisolone : this chemical can be used as a glucocorticoid. And it is used for rheumatoid arthritis, collagen diseases, allergic disease, ophthalmic disease, lymphatic leukemia, soft tissue inflammation and hemolytic anemia.
When you are using this chemical, please be cautious about it as the following:
Moderately toxic by intraperitoneal route. A steroid hormone. Human systemic effects include arrhythmias, blood pressure lowering, heart rate changes, increased body temperature, pulse rate increase, respiratory depression. When heated to decomposition it emits acrid smoke and irritating fumes. Wear suitable protective clothing, gloves and eye/face protection when you are using it. Do not breathe dust. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. Store it at temperature of 0-6°C.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C\1\C=C/[C@]4(/C(=C/1)[C@@H](C)C[C@@H]2[C@@H]4[C@@H](O)C[C@@]3([C@@](O)(C(=O)CO)CC[C@@H]23)C)C;
(2)InChI: InChI=1/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1;
(3)InChIKey: VHRSUDSXCMQTMA-PJHHCJLFBP
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 2292mg/kg (2292mg/kg) | Drugs in Japan Vol. 6, Pg. 832, 1982. | |
| rat | LD50 | oral | > 4gm/kg (4000mg/kg) | Drugs in Japan Vol. 6, Pg. 832, 1982. | |
| women | TDLo | intravenous | 20mg/kg/45M-C (20mg/kg) | CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) | Journal of Rheumatology. Vol. 13, Pg. 477, 1986. |
| women | TDLo | intravenous | 60mg/kg/3D-I (60mg/kg) | CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION | Annals of Internal Medicine. Vol. 99, Pg. 282, 1983. |
| women | TDLo | parenteral | 2400ug/kg (2.4mg/kg) | CARDIAC: CHANGE IN RATE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | British Journal of Anesthesia. Vol. 69, Pg. 422, 1992. |

